Avidity Biosciences Inc.

NASDAQ: RNA · Real-Time Price · USD
46.93
0.86 (1.87%)
At close: Aug 15, 2025, 1:12 PM

Avidity Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
10.9M 9.56M 9.22M 9.33M
Cost of Revenue
2.78M 2.1M 1.39M 639K
Gross Profit
10.9M 7.46M 7.84M 8.69M
Operating Income
-378.94M -235.6M -178.91M -118.05M
Interest Income
56.88M 23.97M 4.97M 104K
Pretax Income
-322.3M -212.22M -174M -118.01M
Net Income
-322.3M -212.22M -174M -118.01M
Selling & General & Admin
86.24M 54.19M 37.73M 26.2M
Research & Development
303.59M 190.97M 150.4M 101.18M
Other Expenses
n/a -2.1M -1.39M -639K
Operating Expenses
389.83M 243.06M 186.75M 126.74M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
389.83M 245.16M 188.14M 127.38M
Income Tax Expense
n/a n/a -4.92M -639K
Shares Outstanding (Basic)
111.58M 73.01M 52.16M 41.43M
Shares Outstanding (Diluted)
111.58M 73.01M 52.16M 41.43M
EPS (Basic)
-2.89 -2.91 -3.34 -2.85
EPS (Diluted)
-2.89 -2.91 -3.34 -2.85
EBITDA
-376.16M -233.5M -177.53M -117.41M
EBIT
-378.94M -235.6M -178.91M -118.05M
Depreciation & Amortization
2.78M 2.1M 1.39M 639K